216 related articles for article (PubMed ID: 8126146)
1. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men.
Bagatell CJ; Heiman JR; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1994 Mar; 78(3):711-6. PubMed ID: 8126146
[TBL] [Abstract][Full Text] [Related]
2. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
3. Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men.
Bagatell CJ; Knopp RH; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1994 Apr; 78(4):855-61. PubMed ID: 8157711
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
5. The effects of exogenous testosterone on sexuality and mood of normal men.
Anderson RA; Bancroft J; Wu FC
J Clin Endocrinol Metab; 1992 Dec; 75(6):1503-7. PubMed ID: 1464655
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
[TBL] [Abstract][Full Text] [Related]
7. Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.
Bagatell CJ; Knopp RH; Vale WW; Rivier JE; Bremner WJ
Ann Intern Med; 1992 Jun; 116(12 Pt 1):967-73. PubMed ID: 1586105
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men.
Bagatell CJ; Heiman JR; Matsumoto AM; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1994 Aug; 79(2):561-7. PubMed ID: 8045977
[TBL] [Abstract][Full Text] [Related]
9. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.
Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625
[TBL] [Abstract][Full Text] [Related]
10. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
[TBL] [Abstract][Full Text] [Related]
11. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
[TBL] [Abstract][Full Text] [Related]
12. Dose effects of the gonadotropin-releasing hormone antagonist, Nal-Glu, combined with testosterone enanthate on gonadotropin levels in normal men.
Bagatell CJ; Rivier JE; Bremner WJ
Fertil Steril; 1995 Jul; 64(1):139-45. PubMed ID: 7789550
[TBL] [Abstract][Full Text] [Related]
13. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
14. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
[TBL] [Abstract][Full Text] [Related]
15. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
[TBL] [Abstract][Full Text] [Related]
16. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
[TBL] [Abstract][Full Text] [Related]
17. The role of aromatization in testosterone supplementation: effects on cognition in older men.
Cherrier MM; Matsumoto AM; Amory JK; Ahmed S; Bremner W; Peskind ER; Raskind MA; Johnson M; Craft S
Neurology; 2005 Jan; 64(2):290-6. PubMed ID: 15668427
[TBL] [Abstract][Full Text] [Related]
18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
Bremner WJ; Bagatell CJ; Steiner RA
J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
[TBL] [Abstract][Full Text] [Related]
20. Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study.
O'Connor DB; Archer J; Wu FC
J Clin Endocrinol Metab; 2004 Jun; 89(6):2837-45. PubMed ID: 15181066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
